E. Traverso

Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)

V. Torri, P. Franzone, F. Alongi, 2019, BMC Cancer.

Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.

G. Poggi, P. Quaretti, L. Villani, 2008, Anticancer Research.

Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.

M. Di Maio, L. Mentuccia, T. Gamucci, 2013, Future oncology.

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088)

V. Torri, F. Alongi, S. Orecchia, 2020, Trials.

The hospital care of patients with cancer: a retrospective analysis of the characteristics of their hospital stay in comparison with other medical conditions.

R. Ippoliti, G. Numico, A. Antonuzzo, 2020, European Journal of Cancer.

Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)

V. Torri, P. Franzone, F. Alongi, 2019, BMC Cancer.